Skip to main content

Treating Esophagus Cancer

The esophagus is part of the gastrointestinal tract. Its function is to move food from the mouth to the stomach for digestion. It is classified as a muscle and is composed of several layers: inner lining, submucosa, muscle layer, and outer layer. Esophagus cancer generally begins growing in the inner layer of the esophagus and can spread to the surround tissues. Cancer cells can also break off and find their way to other parts of the body inducing other cancerous tumors to grow. This is called metastasis. It is unknown what causes esophageal cancer but risk factors that increase your chances of developing the disease include being over the age of 65, being male, smoking, drinking heavily, unhealthy died, obesity, and acid reflux.

Esophagus cancer is asymptomatic meaning it typically does not present any symptoms. However difficulty swallowing, unexplained weight loss, chest pain, and fatigue have been associated with the disease. It is a good idea to make an appointment with your health care provider for screening if these symptoms persist and become worrisome. Your doctor may diagnose the disease by having you drink a barium solution and taking x-rays of your throat. He may also use an endoscopy to look directly at the tissue in your esophagus. If cancerous tissue is found, a biopsy is usually performed to confirm the diagnosis and to determine if the cancer is malignant or benign.

There are several treatment options available for esophagus cancer. This includes chemotherapy, radiation therapy, and surgery. The type of treatment prescribed generally depends on the severity of the disease, its location, and whether it has spread to other parts of your body. Surgery may be performed at the outset to remove very small tumors found at the beginning stages of the disease. If the disease is advanced enough, however, more aggressive surgical intervention may include removing part of the esophagus (esophagectomy) or part of the throat as well as the upper part of the stomach (esophagogastrectomy). Chemotherapy and radiation therapy may also be prescribed in conjunction with surgery.

There is no cure for esophagus cancer. Treatment of the disease is difficult even with current medical technology. Patients suffering from this disease may be encouraged to participate in clinical trials so the more effective treatment options may be found. It is best to speak with your health care provider about all of your treatment options as well as their associated benefits and risks.

A leading team of cardiothoracic surgeons in Washington State, providing cutting-edge heart surgery, lung surgery, and surgery of the Aorta and the Esophagus in the Seattle and Tacoma areas.


View the original article here

Popular posts from this blog

Lung cancer survival rate - Stage 2 lung cancer

When a person looks for a medical professional about the stage 2 lung cancer, one of the first questions that come to mind is: what is my lung cancer survival rate? This is largely influenced by the medical records showing that lung cancer is one of the lowest chances of survival of cancers in the world. One must realize that these statistics are only numbers and a variety of factors that can affect your chances of being cured. The lung cancer survival rate is affected by several variables. One such variable is age. Younger people tend to have a greater chance of survival for people over 50. This is due to the strong natural defenses younger than the older. Medical records also indicate that women with lung cancer in stage 2 have a greater ability to be cured of their male counterparts the parties. The spread of malignant tumor is a very important factor in determining the survival of lung cancer exchange rate. The tumors may spread from the lung tissu...

Analysis: Life saving lung cancer test to set off cost debate

By Bill Berkrot NEW YORK | Wed Jun 29, 2011 6:07pm EDT NEW YORK (Reuters) - A landmark study showing that routine lung screening of heavy smokers and former smokers using low dose CT scans could save thousands of lives is sure to set off a fierce debate about the cost of such testing on an overburdened healthcare system. The U.S. National Cancer Institute studied more than 53,000 people between the ages of 55 and 74 deemed at high risk of developing lung cancer. It found that screening with the three-dimensional X-rays cut deaths by 20 percent. Details of the study and a discussion of its implications were published on Wednesday in the New England Journal of Medicine, lending additional weight to initial findings that were released in November. The discussion noted that radiologists using more advanced CT equipment than was available for the study could lead to an even larger reduction in lung cancer deaths. At the same time, the potential for many more false positive results could ri...

Alternative Pain Therapy for Breast, Prostate and Lung Cancer

Alternative Pain Therapy for Breast, Prostate and Lung Cancer MIAMI--(Healthcare Sales & Marketing Network)-- Bio-Nucleonics? lead product Strontium Chloride Sr-89 Injection USP (Strontium-89), which is the generic version of Metastron?, is an option to consider for metastatic cancer bone pain therapy, typically caused by advanced stage breast, prostate or lung cancer. Strontium Chloride Sr-89 Injection USP (Strontium-89) is a radioactive pharmaceutical injection to relieve bone pain in patients with painful skeletal metastases. In the body, Strontium acts similar to calcium and is preferentially taken up in osteoblastic tissue while the unabsorbed isotope is excreted in the urine the first 2 to 3 days following injection, clearing rapidly from the blood and selectively localizing in bone mineral. Uptake of strontium by bone occurs preferentially in sites of active osteogenesis; thus primary bone tumors and areas of metastatic involvement (blastic lesions) can accumulate significa...